PML(NLS¯) protein: A novel marker for the early diagnosis of acute promyelocytic leukemia

PML(NLS¯)蛋白:急性早幼粒细胞白血病早期诊断的新标志物

阅读:7
作者:Zhi-Ling Shan, Xin-Yu Zhu, Peng-Peng Ma, Hui Wang, Jianbin Chen, Jun Li, Liang Zhong, Bei-Zhong Liu

Abstract

Promyelocyte leukemia‑retinoic acid receptor α (PML‑RARα) is known as a fusion gene of acute promyelocytic leukemia (APL). Previous studies have reported that neutrophil elastase (NE) cleaves PML‑RARα in early myeloid cells, which leads to the removal of the nuclear localization signal (NLS) in PML and increases the incidence of APL. The resultant PML without the NLS is termed PML(NLS‑). The aim of the present study was to verify the existence and location of the PML(NLS‑) protein in NB4 cells. NB4 cells underwent electroporation with the pCMV‑HA‑NE plasmid to form NB4‑HA‑NE cells, which were then transplanted to produce tumors in nude mice and samples were collected from patients with APL. Western blot analysis, an immunofluorescence assay, confocal laser microscopy and immunohistochemistry were performed to detect the expression and localization of the PML(NLS‑) protein. The findings demonstrated that PML(NLS‑) was detectable in the cytoplasm of NB4‑HA‑NE cells, the tumors in nude mice and in neutrophils from patients with APL. This indicated that PML(NLS‑) may be an effective and novel target for the diagnosis of APL.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。